Pioglitazone

Product NDC
70518-2431
11-digit product format
705182431
Labeler code
70518
Product ID
70518-2431_dbd872ce-ef3b-541a-e053-2a95a90a091b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pioglitazone
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA200268
Marketing category
ANDA
Marketing start
2019-11-18
Marketing end
0000-00-00
Substance
PIOGLITAZONE HYDROCHLORIDE
Active strength
45 mg/1
Pharmacologic classes
PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2431PIOGLITAZONE TABLET [REMEDYREPACK INC.]9Legacy NDC20250316_db4564ed-1595-403a-a20d-8dad515c9e56.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2431-07051824310090 TABLET in 1 BOTTLE, PLASTIC (70518-2431-0) 90 tablet2019-11-180000-00-00NoNoCurrent
70518-2431-17051824310190 TABLET in 1 BOTTLE, PLASTIC (70518-2431-1) 90 tablet2021-09-230000-00-00NoNoCurrent